mRNA-based immunotherapy platform targeting endometrial cancer.
Saved in:
| Title: | mRNA-based immunotherapy platform targeting endometrial cancer. |
|---|---|
| Authors: | Freyberg M; Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany., Dierks M; Institute of Pathology, University Hospital Brandenburg an der Havel Brandenburg and Medical School Theodor Fontane (MHB), Brandenburg, Germany., Nass N; Institute of Pathology, University Hospital Brandenburg an der Havel Brandenburg and Medical School Theodor Fontane (MHB), Brandenburg, Germany., George C; Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany., Geffken M; Department of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ignatov A; Department of Gynecology and Obstetrics, Otto-von-Guericke University, Magdeburg, Germany. atanas.ignatov@med.ovgu.de., Kalinski T; Institute of Pathology, University Hospital Brandenburg an der Havel Brandenburg and Medical School Theodor Fontane (MHB), Brandenburg, Germany. Thomas.Kalinski@uk-brandenburg.de., Ignatova Z; Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany. zoya.ignatova@uni-hamburg.de. |
| Source: | Journal of translational medicine [J Transl Med] 2025 Dec 05; Vol. 24 (1), pp. 82. Date of Electronic Publication: 2025 Dec 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
